Literature DB >> 6540405

Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland.

J P Larsen, J A Aarli, H Nyland, T Riise.   

Abstract

Prevalence studies and investigations based on death certificates and disability assistance have shown that western Norway has been a medium-frequency area for MS. The prevalence of definite/probable MS on January 1, 1963 was 20.1/100,000. Based on the same diagnostic criteria, the prevalence of definite/probable MS had increased to 59.8/100,000 on January 1, 1983 in the county of Hordaland. We consider this increase of MS cases in the population to be due to real biologic changes, although factors affecting the figures were found. Most important was a reduction in the interval from onset to diagnosis. The rise in prevalence was also supported by an increase in the annual incidence of the disease. The incidence rate averaging 2 per 100,000 in the period 1953 to 1962 rose to 3.5 for 1968 to 1977. This marked rise in prevalence/incidence supports the concept that an exogenous factor is important in the pathogenesis of MS.

Entities:  

Mesh:

Year:  1984        PMID: 6540405     DOI: 10.1212/wnl.34.9.1202

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses.

Authors:  M-L Sumelahti; P J Tienari; M Hakama; J Wikström
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  The clustering of multiple sclerosis in various administrative subunits of western Poland.

Authors:  M Wender; P Kowal; D Pruchnik-Grabowska; H Hertmanowska; J Marcinkowski; M Zielińska; I Namysł
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

3.  Multiple sclerosis in the province of Ferrara : evidence for an increasing trend.

Authors:  E Granieri; N-T Economou; R De Gennaro; M R Tola; L Caniatti; V Govoni; E Fainardi; I Casetta
Journal:  J Neurol       Date:  2007-11-16       Impact factor: 4.849

Review 4.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 5.  Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.

Authors:  N Grytten; Ø Torkildsen; K-M Myhr
Journal:  Acta Neurol Scand       Date:  2015       Impact factor: 3.209

6.  A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.

Authors:  N Grytten; J H Aarseth; H M B Lunde; K M Myhr
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-24       Impact factor: 10.154

7.  29 Year Old Man with Multiple Sclerosis and Schizophrenia: A Case Report.

Authors:  Nahid Noorani; Fateme Hadi; Hamid Reza Ahmadkhaniha
Journal:  Electron Physician       Date:  2016-12-25

8.  Potential role of paramyxoviruses in multiple sclerosis.

Authors:  S D Cook; B Blumberg; P C Dowling
Journal:  Neurol Clin       Date:  1986-02       Impact factor: 3.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.